Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Denning

Showing results (161-170 of 466) with videos related to

Pageof 47
Sort By:
The Journal of Antimicrobial Chemotherapy|March 27, 2004
Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and CandidaPeter A Warn, A Sharp, J Guinea, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 3, 2012
Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitizationLivingstone Chishimba, Robert M Niven, John Cooley, et al.
Mycoses|February 15, 2022
Burden of serious fungal infections in HondurasNelson Iván Agudelo Higuita, Diana Varela Bustillo, David W Denning
International Journal of Antimicrobial Agents|December 18, 2009
Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatusPeter A Warn, Andrew Sharp, Graham Morrissey, et al.
Mycoses|June 17, 2020
Intravenous therapy for chronic pulmonary aspergillosis: A systematic review and meta-analysisFelix Bongomin, Lucy Grace Asio, Ronald Olum, et al.
Scandinavian Journal of Infectious Diseases|September 30, 2006
Acute pulmonary aspergillosis in immunocompetent subjects after exposure to bark chippingsMaiken Cavling Arendrup, B Ronan O'driscoll, Eskild Petersen, et al.
Open Forum Infectious Diseases|May 16, 2020
Chronic Pulmonary Histoplasmosis-A Scoping Literature ReviewJacob Baker, Chris Kosmidis, Anna Rozaliyani, et al.
Plos One|April 11, 2018
Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosisFelix Bongomin, Chris Harris, Gemma Hayes, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2016
Comment on: Antifungal therapy: drug-drug interactions at your fingertipsJennifer S Bartholomew, Susan Banfield, Graham T Atherton, et al.
Therapeutic Advances in Infectious Disease|May 17, 2021
Drug-drug interaction database for safe prescribing of systemic antifungal agentsSaarah Niazi-Ali, Graham T Atherton, Marcin Walczak, et al.
Pageof 47

Showing results (161-170 of 466) with videos related to

Sort By:
Pageof 47
The Journal of Antimicrobial Chemotherapy|March 27, 2004
Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and CandidaPeter A Warn, A Sharp, J Guinea, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 3, 2012
Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitizationLivingstone Chishimba, Robert M Niven, John Cooley, et al.
Mycoses|February 15, 2022
Burden of serious fungal infections in HondurasNelson Iván Agudelo Higuita, Diana Varela Bustillo, David W Denning
International Journal of Antimicrobial Agents|December 18, 2009
Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatusPeter A Warn, Andrew Sharp, Graham Morrissey, et al.
Mycoses|June 17, 2020
Intravenous therapy for chronic pulmonary aspergillosis: A systematic review and meta-analysisFelix Bongomin, Lucy Grace Asio, Ronald Olum, et al.
Scandinavian Journal of Infectious Diseases|September 30, 2006
Acute pulmonary aspergillosis in immunocompetent subjects after exposure to bark chippingsMaiken Cavling Arendrup, B Ronan O'driscoll, Eskild Petersen, et al.
Open Forum Infectious Diseases|May 16, 2020
Chronic Pulmonary Histoplasmosis-A Scoping Literature ReviewJacob Baker, Chris Kosmidis, Anna Rozaliyani, et al.
Plos One|April 11, 2018
Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosisFelix Bongomin, Chris Harris, Gemma Hayes, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2016
Comment on: Antifungal therapy: drug-drug interactions at your fingertipsJennifer S Bartholomew, Susan Banfield, Graham T Atherton, et al.
Therapeutic Advances in Infectious Disease|May 17, 2021
Drug-drug interaction database for safe prescribing of systemic antifungal agentsSaarah Niazi-Ali, Graham T Atherton, Marcin Walczak, et al.
Pageof 47